Pioneering bioactive compounds and metabolic formulas engineered under rigorous scientific validation for target-specific wellness.
In the modern era, the paradigm of healthcare has fundamentally shifted from reactive treatment to proactive prevention. Food supplements for daily nutritional support have transitioned from basic multivitamins to complex, scientifically validated formulations designed to target cellular health, metabolic efficiency, and clinical recovery. Today, the global supplement industry is undergoing a technological revolution, driven by advancements in biotechnology, molecular biology, and precision medicine.
The global dietary supplements market is projected to exceed USD 240 billion by 2030, exhibiting a compound annual growth rate (CAGR) of over 6.5%. This growth is fueled by an aging population, rising disposable income, and a heightened awareness of preventive health. Industrially, the market is moving away from generic formulations. Today's commercial success belongs to manufacturers who can deliver bioavailable active ingredients, clean labels, and clinical efficacy. The supply chain has become highly specialized, with contract manufacturers providing advanced delivery mechanisms such as liposomal encapsulation, nano-emulsions, and sustained-release pellets to maximize therapeutic outcomes.
Three mega-trends are shaping the future of daily nutritional support: personalization, biotechnology-driven sourcing, and medical integration. Personalized nutrition utilizes genetic profiling, gut microbiome analysis, and metabolic biomarkers to synthesize custom daily supplement packs. Biotechnology is replacing raw agricultural extraction with precision fermentation to produce high-purity bioactive peptides, carotenoids, and amino acids. Furthermore, the boundaries between pharmaceuticals and nutraceuticals are blurring, leading to the rapid expansion of Foods for Special Medical Purposes (FSMP) that require strict regulatory compliance and robust clinical trials.
Leveraging state-of-the-art bioprocessing and proprietary scientific research, our catalog spans clinical-grade therapeutic diets, patient-specific staple foods, and premium lifestyle supplements.
Designed for individuals requiring strict dietary control due to metabolic or renal disorders, utilizing proprietary processing methods to ensure taste and nutritional compliance:
Spanning eight major demographic categories, these products integrate patented bio-active formulas for comprehensive daily support:
Recognized in official procurement catalogs, this series is engineered for high-performance athletes requiring clean, doping-free nutritional supplementation:
Clinical nutrition solutions developed to serve as primary or supplemental dietary sources for patients with compromised gastrointestinal or metabolic functions:
Operating in collaboration with the scientific research platforms of the Chinese Academy of Sciences, our company integrates R&D, advanced manufacturing, and global distribution. We focus on specialized medical nutrition, therapeutic diets, patient staple foods, and sports nutrition to provide comprehensive, science-backed solutions for global health challenges.
The efficacy of food supplements for daily nutritional support is best understood through their application in real-world clinical and daily scenarios. Here, we analyze how specialized formulations solve complex biological challenges.
For patients suffering from Chronic Kidney Disease (CKD), protein intake must be tightly restricted to prevent nitrogenous waste buildup, yet they must avoid protein-energy wasting. Our biological protein removal technology allows patients to consume traditional staples like rice and noodles without overloading their kidneys, preserving their quality of life and compliance with medical diets.
Phenylketonuria (PKU) requires a lifetime of phenylalanine-free nutrition. Infants diagnosed with PKU cannot metabolize this essential amino acid, which can lead to severe cognitive impairment if untreated. Our phenylalanine-free amino acid-based infant formulas provide the necessary protein building blocks, enabling normal growth and development from birth through the critical first year.
Gastrointestinal surgeries require clear liquid diets and low-residue nutrition to minimize bowel movements and prevent infection. Formulations like Enli'an leverage nano-emulsion technology to deliver high-calorie, easily absorbable nutrients with minimal osmotic pressure, reducing post-operative complications and accelerating patient discharge.
Our product architecture serves two primary market segments: clinical patient populations and the mass health consumption market.
From clinical environments to daily life, our supplements integrate seamlessly into diverse routines:
Our competitive edge lies in scientific research, clinical validation, and advanced manufacturing processes:
We tailor our products and supply chain to meet the unique dietary habits and regulatory structures of our target markets:
Zhongen (Tianjin) Medical Technology Co., Ltd. (SINOFNHealth) is a subsidiary of the Chinese Academy of Sciences, representing its dedicated venture into specialized medical nutrition and dietary solutions. With 13 years of industry expertise and a total investment of RMB 350 million, we have established ourselves as pioneers in the fields of FSMP and therapeutic diets.
Our portfolio includes 89 intellectual property rights, over 1,500 mature formulations, and an annual output of more than 100 new products. As a trusted supplier for the General Administration of Sport of China, our formulations support national teams, while our medical division supplies critical nutritional support to over 204 tertiary hospitals nationwide.
Explore our full selection of clinically validated dietary supplements, functional premixes, and metabolic foods.
Partner with a subsidiary of the Chinese Academy of Sciences to deliver high-quality, clinically validated nutrition products globally.